Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

249 views

Visitors from

US 53%·

AU 33%·

IN 7%·

GB 2%·

FR 1%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?

By: MarketBeat

October 30, 2024 at 09:30 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Entrance gate card Access Security system - stock image

Shares of Evolv Technologies Inc. (NASDAQ: EVLV) are down approximately 45% after a group of independent board directors acknowledged accounting irregularities that would delay the company’s quarterly Form 10-Q filing.

The issue concerns misconduct by some of the company’s employees regarding sales practices. Specifically, the company recognized premature or incorrect revenue regarding sales that were subject to extra-contractual terms and conditions. The misconduct will cause Evolv to restate financial statements made over the two years spanning Q2 2022 and Q2 2024.

The company says the incorrect or premature revenue totals approximately $4 million to $6 million over the two-year period. To put that in perspective, in its fiscal year 2023, the company generated $80.42 million in revenue. And it’s on pace to beat that number in 2024.

The Company May Have Bigger Concerns

To be clear, accounting irregularities, even if done without intent, should be taken seriously. What makes these charges more serious is that employees seem to have had knowledge of their fraudulent sales practices.

The larger questions the investigation will have to determine are: What did the company know, and when did it know it?

But that news comes on the heels of more bad news that Evolv received this month. The company was conducting a pilot program with the city of New York. The program placed Evolv Express systems in select subway stations. However, in over 3,000 searches, the system registered 118 false positives and failed to detect any firearms.

This wouldn’t be the first time Evolv has faced scrutiny. Earlier this year, the company was cited in a class action lawsuit that raised questions about the effectiveness of its products and/or the veracity of its marketing claims.

However, some of the controversies is due to the fact that Evolv doesn’t put its products through regulatory testing, which the company says fails to reflect real-world conditions appropriately.

And the company cites an ever-increasing threat environment, poor visitor experience, costly security labor shortages, challenging worker retention, and a lack of security and visitor data as key reasons that the companies are looking for its products.

The company is also showing growth in annual recurring revenue (ARR). In its most recent quarter, 49% of booked ARR was from existing customers. These are customers that have tested and deployed Evolv’s products and are now choosing to expand their contracts.

Analyst Reaction Has Been Swift

Obviously, the company’s upcoming earnings report, due out on November 14, will play a key role in how investors feel about EVLV stock. However, analysts wasted no time in weighing in on the Evolv news.

The Evolv analyst forecasts on MarketBeat show four downgrades for EVLV stock. The most significant factor comes from TD Cowen, which downgraded the stock from a Strong Buy to a Strong Sell.

Getting Involved With EVLV Stock

If you have a short-term mindset, there are better options among technology stocks. Short interest is above 13%, and although it was down over 5% in the last month, short sellers may take an opportunity to put more pressure on the stock. However, as of midday trading on October 29, EVLV stock looks to be finding support around $2.40. That’s about 20% above the stock’s 52-week low.

That suggests the worst may be over. And a drop of over 40% on news that impacts a small fraction of the company's revenue seems like an overreaction. Buy-and-hold investors may see this as a buyable dip, but you may want to wait until after earnings to make that decision.

The picture looks a little clearer for traders, particularly options traders. The options chain shows a highly bullish puts-to-call (PTC) ratio in November and December. That suggests bullish sentiment. However, that sentiment reverses in January 2025 to become bearish. There could be many reasons for that, including concerns about how the economy may impact capital expenditures for the company’s customers.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	272.05	+0.00 (0.00%)
AAPL	276.83	+0.00 (0.00%)
AMD	341.54	+0.00 (0.00%)
BAC	52.19	+0.00 (0.00%)
GOOG	379.64	+0.00 (0.00%)
META	610.41	+0.00 (0.00%)
MSFT	413.62	+0.00 (0.00%)
NVDA	198.48	+0.00 (0.00%)
ORCL	180.29	+0.00 (0.00%)
TSLA	392.51	+0.00 (0.00%)